|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celltech |
 |
|
| Fate | Acquired |
|---|---|
| Successor | UCB |
| Founded | 1980 |
| Defunct | 2004 |
| Headquarters | Slough, UK |
| Key people | Goran Ando (CEO) |
| Industry | Biotechnology |
Celltech Group plc was a leading British-based biotechnology business based in Slough. It was listed on the London Stock Exchange and was a constituent of the FTSE 100 Index.
The Company was founded by Gerald Fairtlough in 1980 with finance from the National Enterprise Board.1
In 1999 the Company led consolidation in the UK biosciences market merging with Chiroscience plc and then buying Medeva plc.2 Then in 2000 it bought Cistron, a US biosciences business.3
It expanded into Germany in 2001 buying Thiemann, a German biosciences business.4
In 2003 it acquired Oxford Glycosciences, a rival British biosciences business.5 It was acquired by UCB, a Belgian drugmaker, in 2004.6 Since then it has been known as UCB Celltech.
The Company was engaged in reaearch and development of therapies for patients with serious diseases. Products included:7
 |
 |
 |
 |
 |
 |
 |
 |